15 – 17 June 2026
TRAINING TIMES
Understand industry approaches for Scale-up, Technology Transfer, and PV applying QbD principles
Gain regulatory insights & guidance on how to realize Technology Transfers and PV
Explore proven best practices in Scale-up for solid dose manufacturing processes
Gain practical knowledge and tools during two interactive sessions and workshops
Take an excellent opportunity to discuss issues & challenges with industry peers and with an expert
Boehringer Ingelheim Pharma, Director Late Stage Drug Product Development
Michael Braun, Ph.D., is currently Director of Late Oral Drug Product Development at Boehringer Ingelheim Pharma GmbH & Co KG in Biberach, Germany. Michael has a Ph.D in Pharmaceutical Technology from University of Bonn, Germany. His career is spanning over 25 years in pharmaceutical R&D, from hands-on formulation work to strategic leadership in drug development and manufacturing. Michael's journey began in 1999 as a Formulation Scientist at Ratiopharm and later as Head of Pharmaceutical Development at Rentschler Pharma in 2003. His career has evolved through various roles in early and late stage drug product development, clinical trial manufacturing and project management at Boehringer Ingelheim since 2006. Over the past two years Michael has worked at the Ridgefield Site, CT as the Director of Solid-State Sciences & API Engineering, driving innovation at the interface of drug substance and product development.
Learn More →
Take a sneak peek at the trainer's presentation.
View PDF →